F.S. Kenny

957 total citations
13 papers, 561 citations indexed

About

F.S. Kenny is a scholar working on Genetics, Cancer Research and Oncology. According to data from OpenAlex, F.S. Kenny has authored 13 papers receiving a total of 561 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Genetics, 7 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in F.S. Kenny's work include Estrogen and related hormone effects (7 papers), Breast Cancer Treatment Studies (4 papers) and HER2/EGFR in Cancer Research (3 papers). F.S. Kenny is often cited by papers focused on Estrogen and related hormone effects (7 papers), Breast Cancer Treatment Studies (4 papers) and HER2/EGFR in Cancer Research (3 papers). F.S. Kenny collaborates with scholars based in United Kingdom, Australia and Switzerland. F.S. Kenny's co-authors include Robert I. Nicholson, Julia M.W. Gee, Ian O. Ellis, Elizabeth A. Musgrove, Rina Hui, J.F.R. Robertson, R.W. Blamey, R. Sutherland, Sarah E. Pinder and Richard Bryce and has published in prestigious journals such as Journal of Clinical Oncology, Oncogene and Annals of Oncology.

In The Last Decade

F.S. Kenny

13 papers receiving 541 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
F.S. Kenny United Kingdom	9	317	243	201	157	93	13	561
Mary Jo Pilat United States	12	230 0.7×	143 0.6×	407 2.0×	72 0.5×	68 0.7×	25	669
Yun Niu China	15	313 1.0×	320 1.3×	379 1.9×	59 0.4×	80 0.9×	31	716
Stefan Kress Germany	11	305 1.0×	223 0.9×	339 1.7×	69 0.4×	33 0.4×	14	649
RA Hawkins United Kingdom	7	209 0.7×	276 1.1×	131 0.7×	162 1.0×	49 0.5×	8	478
Richard E. Heinz United States	8	249 0.8×	181 0.7×	199 1.0×	138 0.9×	97 1.0×	15	528
Saro Oriana Italy	11	242 0.8×	177 0.7×	155 0.8×	61 0.4×	74 0.8×	35	590
Richard Y. Lee United States	6	188 0.6×	160 0.7×	394 2.0×	253 1.6×	40 0.4×	6	614
Akihiro Naito Japan	16	170 0.5×	193 0.8×	443 2.2×	71 0.5×	104 1.1×	52	738
Randall Rago United States	10	112 0.4×	107 0.4×	247 1.2×	59 0.4×	145 1.6×	18	526
Widya Johannes United States	6	189 0.6×	135 0.6×	417 2.1×	136 0.9×	258 2.8×	8	757

Countries citing papers authored by F.S. Kenny

Since Specialization

Citations

This map shows the geographic impact of F.S. Kenny's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F.S. Kenny with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F.S. Kenny more than expected).

Fields of papers citing papers by F.S. Kenny

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F.S. Kenny. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F.S. Kenny. The network helps show where F.S. Kenny may publish in the future.

Co-authorship network of co-authors of F.S. Kenny

This figure shows the co-authorship network connecting the top 25 collaborators of F.S. Kenny. A scholar is included among the top collaborators of F.S. Kenny based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F.S. Kenny. F.S. Kenny is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Johnston, Simon J., F.S. Kenny, Binafsha Manzoor Syed, et al.. (2012). A randomised trial of primary tamoxifen versus mastectomy plus adjuvant tamoxifen in fit elderly women with invasive breast carcinoma of high oestrogen receptor content: long-term results at 20 years of follow-up. Annals of Oncology. 23(9). 2296–2300. 35 indexed citations

Johnston, Simon J., F.S. Kenny, Binafsha Manzoor Syed, et al.. (2011). A randomized controlled trial of primary tamoxifen versus mastectomy plus adjuvant tamoxifen in fit elderly women with breast carcinoma of high estrogen receptor content: Long-term results at 20 years of follow-up.. Journal of Clinical Oncology. 29(15_suppl). 536–536. 1 indexed citations

Chakrabarti, J., F.S. Kenny, Binafsha Manzoor Syed, et al.. (2010). A randomised trial of mastectomy only versus tamoxifen for treating elderly patients with operable primary breast cancer—Final results at 20-year follow-up. Critical Reviews in Oncology/Hematology. 78(3). 260–264. 40 indexed citations

Kenny, F.S., Peter C. Willsher, Julia M.W. Gee, et al.. (2001). Change in Expression of ER, bcl-2 and MIB1 on Primary Tamoxifen and Relation to Response in ER Positive Breast Cancer. Breast Cancer Research and Treatment. 65(2). 135–144. 32 indexed citations

Kenny, F.S., Julia M.W. Gee, Robert I. Nicholson, et al.. (2001). Effect of dietary GLA+/?tamoxifen on the growth, ER expression and fatty acid profile of ER positive human breast cancer xenografts. International Journal of Cancer. 92(3). 342–347. 19 indexed citations

Kenny, F.S., Sarah E. Pinder, Ian O. Ellis, et al.. (2000). Gamma linolenic acid with tamoxifen as primary therapy in breast cancer. International Journal of Cancer. 85(5). 643–648. 81 indexed citations

Gee, Julia M.W., Peter C. Willsher, F.S. Kenny, et al.. (1999). Endocrine response and resistance in breast cancer: a role for the transcription factor Fos. International Journal of Cancer. 84(1). 54–61. 23 indexed citations

Kenny, F.S., Rina Hui, Elizabeth A. Musgrove, et al.. (1999). Overexpression of cyclin D1 messenger RNA predicts for poor prognosis in estrogen receptor-positive breast cancer.. PubMed. 5(8). 2069–76. 189 indexed citations

Hui, Rina, Jonathon Ball, R. Douglas Macmillan, et al.. (1998). EMS1 gene expression in primary breast cancer: relationship to cyclin D1 and oestrogen receptor expression and patient survival. Oncogene. 17(8). 1053–1059. 77 indexed citations

10.

Kenny, F.S., et al.. (1998). Gamma linolenic acid with tamoxifen as primary therapy in breast cancer. European Journal of Cancer. 34. S18–S19. 5 indexed citations

11.

Kenny, F.S., Peter C. Willsher, Julia M.W. Gee, et al.. (1998). Change in expression of ER and BCL-2 predict for quality and duration of response in endocrine sensitive breast cancer. European Journal of Cancer. 34. S82–S82. 2 indexed citations

12.

Kenny, F.S., J.F.R. Robertson, Ian O. Ellis, C.W. Elston, & R.W. Blarney. (1998). Long-term follow-up of elderly patients randomized to primary tamoxifen or wedge mastectomy as initial therapy for operable breast cancer. The Breast. 7(6). 335–339. 56 indexed citations

13.

Kenny, F.S., Peter C. Willsher, Julia M.W. Gee, et al.. (1997). 0-10. Change in expression of ER and bcl-2 predict for quality and duration of response in endocrine sensitive breast cancer. The Breast. 6(4). 227–227. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact